Trial Profile
Clinical Trials Insight: 700037575
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 30 Sep 2008
Price :
$35
*
At a glance
- Drugs Epratuzumab (Primary) ; Veltuzumab
- Indications Non-Hodgkin's lymphoma
- Focus Registrational; Therapeutic Use
- Sponsors Immunomedics
- 30 Sep 2008 New trial record.